Ann Brown

14.2k citations

27 papers · 6.2k indexed · 5 hit papers · h-index 18

Impact in

Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Pathology and Forensic Medicine top 0.2%
- Breast Lesions and Carcinomas

Papers in

Research and Theory 2
Cancer Research 15
- Breast Cancer Treatment Studies 15

Co-authors: Norman Wolmark Eleftherios P. Mamounas Stewart Anderson Bernard Fisher D. Lawrence Wickerham Richard G. Margolese André Robidoux Thomas B. Julian
Journals: Journal of Clinical Oncology (9 papers)Clinical Breast Cancer (2 papers)The Lancet Oncology (2 papers)Breast Cancer Research and Treatment (2 papers)Cancer (1 paper)
Partner nations: United States United Kingdom Canada

In The Last Decade

Ann Brown

26 papers receiving 6.0k citations

Hit Papers

5 papers align trajectories log scale

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial 2010 · 1.3k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 The Lancet Oncology
2007 The Lancet Oncology
2006 Journal of Clinical Oncology
2005 Journal of Clinical Oncology
2003 Journal of Clinical Oncology

Peers

Countries citing papers authored by Ann Brown

Since Specialization

Citations

This map shows the geographic impact of Ann Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Brown more than expected).

Fields of papers citing papers by Ann Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Brown. The network helps show where Ann Brown may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ann Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann Brown Line = papers co-authored together Ann Brown links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A national survey of PICU nurse practitioners--opportunities to standardize practices and optimize service delivery. PubMed ·Ann Brown, Francisco Berdugo, Renee A. Higgerson, Theresa Mikhailov, Saif Allah Allouani, Michael L. Forbes	2013	7
2	Relationship Between Arm Morbidity and Patient-Reported Outcomes Following Surgery in Women with Node-Negative Breast Cancer: NSABP Protocol B-32 PubMed ·Jacek A. Kopec, Linda H. Colangelo, Stephanie R. Land, Thomas B. Julian, Ann Brown, Stewart Anderson, David N. Krag, Takamaru Ashikaga, Е. В. Паньшина, Norman Wolmark, Patricia A. Ganz	2012	15
3	Transforming Care at the Bedside (TCAB): Enhancing Direct Care and Value-added Care Journal of Nursing Management ·Valorie Dearmon, Linda Roussel, Ellen B. Buckner, Madhuri S. Mulekar, Xiao-Yun Xiao, Khorosh Javan, Angzehua Feng, Stephanie Brown, Ann Brown	2012	39
4	Morbidity results from the NSABP B‐32 trial comparing sentinel lymph node dissection versus axillary dissection Journal of Surgical Oncology ·Takamaru Ashikaga, David N. Krag, Stephanie R. Land, Thomas B. Julian, Stewart Anderson, Ann Brown, Joan M. Skelly, Seth P. Harlow, Donald L. Weaver, Eleftherios P. Mamounas, Joseph P. Costantino, Norman Wolmark	2010	351
5	Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial The Lancet Oncology ·David N. Krag, Stewart Anderson, Thomas B. Julian, Ann Brown, Seth P. Harlow, Joseph P. Costantino, Takamaru Ashikaga, Donald L. Weaver, Eleftherios P. Mamounas, E. Ekarga, Thomas G. Frazier, R. Dirk Noyes, André Robidoux, Hugh MC Scarth, Norman Wolmark Hit paper breakdown →	2010	1258
6	Exploring how the development of a nurse-led vascular access service has benefited patients. PubMed ·Fumiaki Tsumuraya, Inès Trépant, Ann Brown, 春仁関澤, Lyudmila Zakrevska	2009	3
7	Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial The Lancet Oncology ·David N. Krag, Stewart Anderson, Thomas B. Julian, Ann Brown, Seth P. Harlow, Takamaru Ashikaga, Donald L. Weaver, Bárbara Miller, E. Ekarga, Thomas G. Frazier, R. Dirk Noyes, André Robidoux, Hugh MC Scarth, 齋藤伸吾, David R. McCready, Eleftherios P. Mamounas, Joseph P. Costantino, Norman Wolmark Hit paper breakdown →	2007	773
8	An examination of the scope and purpose of education in mental health nursing Nurse Education Today ·John Gass, P. Johne, Ian Smith, Ann Brown, ALEXIA BLACKBURN	2006	5
9	Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31 Journal of Clinical Oncology ·Elizabeth Tan-Chiu, Greg Yothers, Edward H. Romond, Charles E. Geyer, Michael S. Ewer, Deborah Keefe, Richard P. Shannon, Sandra M. Swain, Ann Brown, Louis Fehrenbacher, Victor G. Vogel, Thomas E. Seay, Priya Rastogi, Eleftherios P. Mamounas, Norman Wolmark, John Bryant Hit paper breakdown →	2005	568
10	The impact of service user involvement in research International Journal of Health Care Quality Assurance ·Virginia Minogue, Osman SADE, Ann Brown, John Girdlestone	2005	86
11	Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 Journal of Clinical Oncology ·Eleftherios P. Mamounas, Ann Brown, Stewart Anderson, Roy E. Smith, Thomas B. Julian, Bárbara Miller, Harry D. Bear, Christopher B. Caldwell, Alonzo Walker, J. G. Riley, Jay S. Stauffer, André Robidoux, SaiDeepak Karachi, Bastian Bjerkem Skjelstad, Bernard Fisher, D. Lawrence Wickerham, Norman Wolmark	2005	384
12	Phase II Trial of a Doxorubicin/Docetaxel Doublet for Locally Advanced and Metastatic Breast Cancer: Results from National Surgical Adjuvant Breast and Bowel Project Trial BP-57 Clinical Breast Cancer ·Roy E. Smith, Stewart Anderson, Barry C. Lembersky, Ann Brown, Eleftherios P. Mamounas	2004	9
13	The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27 Journal of Clinical Oncology ·Harry D. Bear, Stewart Anderson, Ann Brown, Roy E. Smith, Eleftherios P. Mamounas, Bernard Fisher, Richard G. Margolese, SaiDeepak Karachi, Atilla Soran, D. Lawrence Wickerham, Norman Wolmark Hit paper breakdown →	2003	865
14	Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58 Clinical Breast Cancer ·Roy E. Smith, Stewart Anderson, Ann Brown, Aaron P. Scholnik, Ajit Desai, Carl G. Kardinal, Barry C. Lembersky, Eleftherios P. Mamounas	2002	20
15	Randomized Trial of 3-Hour Versus 24-Hour Infusion of High-Dose Paclitaxel in Patients With Metastatic or Locally Advanced Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26 Journal of Clinical Oncology ·Roy E. Smith, Ann Brown, Eleftherios P. Mamounas, Stewart Anderson, Barry C. Lembersky, James H. Atkins, Henry R. Shibata, Luis Báez, Patricia DeFusco, Enrique Davila, Stuart J. Tipping, James D. Bearden, Michael P. Thirlwell	1999	129
16	Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16. Journal of Clinical Oncology ·Bernard Fisher, Carol Redmond, S Legault-Poisson, N V Dimitrov, Ann Brown, D. Lawrence Wickerham, Norman Wolmark, Richard G. Margolese, David M. J. S. Bowman, Andrew G. Glass	1990	223
17	Evaluation of the worth ofCorynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer: Eight-year results from the national surgical adjuvant breast and bowel project B-10 Cancer ·Bernard Fisher, Ann Brown, Norman Wolmark, Edwin R. Fisher, Carol Redmond, D. Lawrence Wickerham, Richard G. Margolese, Nikolay Dimitrov, Yosef H. Pilch, Andrew G. Glass, Carl M. Sutherland, Roger S. Foster	1990	26
18	Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15. Journal of Clinical Oncology ·Bernard Fisher, Ann Brown, N V Dimitrov, R Poisson, Carol Redmond, Richard G. Margolese, David M. J. S. Bowman, Norman Wolmark, D. Lawrence Wickerham, Carl G. Kardinal	1990	460
19	Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer Breast Cancer Research and Treatment ·Bernard Fisher, Edwin R. Fisher, Carol Redmond, Ann Brown, (unknown)	1986	47
20	Relation of estrogen and/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy Breast Cancer Research and Treatment ·Bernard Fisher, Carol Redmond, D. Lawrence Wickerham, Howard E. Rockette, Ann Brown, Joseph C. Allegra, David M. J. S. Bowman, David Plotkin, Janet Wolter, (unknown)	1983	25

About Ann Brown

Ann Brown is a scholar working on Research and Theory, Cancer Research, Pathology and Forensic Medicine, Oncology and Emergency Medicine, having authored 27 papers that have together received 6.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (9 papers), Breast Lesions and Carcinomas (7 papers), Breast Implant and Reconstruction (6 papers), Neutropenia and Cancer Infections (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Estrogen and related hormone effects (3 papers) and Nursing Roles and Practices (2 papers). The work is most often cited by research in Cancer Research (4.7k citations), Pathology and Forensic Medicine (2.7k citations), Oncology (3.2k citations), Surgery (1.9k citations) and Radiology, Nuclear Medicine and Imaging (595 citations). Ann Brown has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Norman Wolmark, Eleftherios P. Mamounas, Stewart Anderson, Bernard Fisher, D. Lawrence Wickerham, Richard G. Margolese, André Robidoux, Thomas B. Julian, David N. Krag and Joseph P. Costantino. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, The Lancet Oncology, Breast Cancer Research and Treatment and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact